The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sapelkin S.V.

Vishnevsky National Medical Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Comments on the article by E.A. Ilyukhin et al. «Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024; 18 (2): 122-131)

Authors:

Sapelkin S.V.

More about the authors

Journal: Journal of Venous Disorders. 2025;19(1): 43‑44

DOI: 10.17116/flebo20251901143

Views: 303

Downloaded: 5

Buy for 300₽
Contact the author
Table of contents

COMMENTS ON THE ARTICLE BY E.A. ILYUKHIN ET AL. «IMPACT OF MICRONIZED PURIFIED FLAVONOID FRACTION ON VENOUS SYMPTOMS AFTER ENDOVENOUS LASER ABLATION: A RANDOMIZED CONTROLLED TRIAL DEMO» (PHLEBOLOGY 2024; 18 (2): 122-131)
COMMENTS ON THE ARTICLE BY E.A. ILYUKHIN ET AL. «IMPACT OF MICRONIZED PURIFIED FLAVONOID FRACTION ON VENOUS SYMPTOMS AFTER ENDOVENOUS LASER ABLATION: A RANDOMIZED CONTROLLED TRIAL DEMO» (PHLEBOLOGY 2024; 18 (2): 122-131)

To cite this article:

Sapelkin SV. Comments on the article by E.A. Ilyukhin et al. «Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024; 18 (2): 122-131). Journal of Venous Disorders. 2025;19(1):43‑44. (In Russ.)
https://doi.org/10.17116/flebo20251901143

Подписка 2025-2 (Journal of Venous Disorders)
 
МСФ на ЯМ
Close metadata

Comments on the article by E.A. Ilyukhin et al. «Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO» (Phlebology 2024; 18 (2): 122-131).

Authors:

Sapelkin S.V.

Vishnevsky National Medical Research Center of Surgery;
Russian Medical Academy of Continuous Professional Education

Received:

22.08.2024

Accepted:

22.09.2024

List of references:

  1. Ilyukhin EA, Kurginyan KhM, Kovalenko KE, Norvardyan AM, Abukhamdan AS, Gevorgyan AA, Kartoev IR. Impact of Micronized Purified Flavonoid Fraction on Venous Symptoms After Endovenous Laser Ablation: a Randomized Controlled Trial DEMO. Journal of Venous Disorders. 2024;18(2):122-131. (In Russ.). https://doi.org/10.17116/flebo2024180211
  2. Perrin M, Eklof B, VAN Rij A, Labropoulos N, Vasquez M, Nicolaides A, Blattler W, Bouhassira D, Bouskela E, Carpentier P, Darvall K, DE Maeseneer M, Flour M, Guex JJ, Hamel-Desnos C, Kakkos S, Launois R, Lugli M, Maleti O, Mansilha A, NEGLéN P, Rabe E, Shaydakov E. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. International Angiology. 2026;35(4):374-398. 
  3. Kamaev AA, Bulatov VL, Vakhratyan PE, Volkov AM, Volkov AS, Gavrilov EK, Golovina VI, Efremova OI, Ivanov OO, Ilyuhin EA, Katorkin SE, Konchugova TV, Kravcov PF, Maksimov SV, Mzhavanadze ND, Pihanova ZhM, Pryadko SI, Smirnov AA, Sushkov SA, Chabbarov RG, Shimanko AI, Yakushkin SN, Aphanova TV, Derkachev SN, Zolotuhin IA, Kalinin RE, Kirienko AI, Kul’chickaya DB, Pelevin AV, Petrikov AS, Rachin AP, Seliverstov EI, Stojko YuM, Suchkov IA.Varicose Veins. Journal of Venous Disorders. 2022;16(1):41-108. (In Russ.). https://doi.org/10.17116/flebo20221601141
  4. Ilyukhin EA. Effectiveness of the oral form of sulodexide in the ALLEGRO observational trial. Journal of Venous Disorders. 2020;14(2):113-121. (In Russ.) https://doi.org/10.17116/flebo202014021113
  5. Ilyukhin EA. Oral Form of Sulodexide for Varicose Veins with Chronic Venous Insufficiency: Data of the ALLEGRO Observational Trial. Journal of Venous Disorders. 2020;14(4):304-310. (In Russ.). https://doi.org/10.17116/flebo202014041304

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.